Astral Resources bid to acquire Maximus Resources could reshape the gold mining landscape, offering shareholders premium value and access to a combined 1.8 million-ounce resource base.
Proteomics International’s breakthrough PromarkerEndo blood test offers a non-invasive, accurate diagnosis for all stages of endometriosis, potentially revolutionising women’s health care.
Green Technology Metals (ASX: GT1) secures a pivotal C$100 million LOI from Export Development Canada, advancing its Seymour Lithium Project toward becoming Ontario’s first lithium producer.
Leeuwin Metals has acquired the Marda Gold Project, unlocking significant exploration potential in Western Australia’s goldfields with plans to rapidly develop high-grade targets.
Trigg Minerals Wild Cattle Creek deposit has seen a 92% boost in contained antimony, solidifying its status as a cornerstone project for Australia’s critical minerals sector.
Altech Batteries (ASX:ATC) secures a strategic offtake deal with Axsol GmbH, delivering defence-ready CERENERGY® GridPack batteries with NATO-aligned credentials.
Tryptamine Therapeutics (ASX:TYP) delivers promising interim results from its Phase 2a trial, with 75% of IBS patients reporting reduced abdominal pain and anxiety, marking a significant step for TRP-8803’s clinical pathway.
Lunnon Metals (ASX:LM8) is redefining Kambalda’s geology, confirming gold mineralisation in the overlooked Lunnon Sediment and paving the way for 2025 exploration at Defiance West.
Invex Therapeutics (ASX:IXC) has demonstrated Exenatide’s ability to improve neuronal cell survival by up to 45% in a 3D Alzheimer’s Disease brain model, marking a promising step in neurodegenerative research.
Asian Battery Metals’ latest drilling at North Oval confirms high-grade copper-nickel sulphides, including 3.6m at 3.85% Cu and 3.82% Ni, with further targets lined up for early 2025 exploration.
